Prelude Therapeutics Stock (NASDAQ: PRLD) stock price, news, charts, stock research, profile.
You can purchase shares of Prelude Therapeutics (NASDAQ:PRLD) through any online brokerage.
Other companies in Prelude Therapeutics’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Serina Therapeutics (AMEX:SER), Kezar Life Sciences (NASDAQ:KZR), Estrella Immunopharma (NASDAQ:ESLA) and Connect Biopharma Hldgs (NASDAQ:CNTB).
Prelude Therapeutics has a consensus price target of $5.50.
The stock price for Prelude Therapeutics (NASDAQ: PRLD) is $0.9099 last updated February 21, 2025 at 9:26 AM EST.
There are no upcoming dividends for Prelude Therapeutics.
Prelude Therapeutics’s Q1 earnings are confirmed for Tuesday, May 6, 2025.
There is no upcoming split for Prelude Therapeutics.
Prelude Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.